跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Bevalast - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Bevalast
Approved
STANDARD
Bevalast
Joint Stock Company Biocad
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
538a7e82c761f90a
Company
Joint Stock Company Biocad
Type
Standard
Approval Details
Approval Id
538a7e82c761f90a
Drug Approval Philippines Name
Bevalast
Product Name
Bevalast
Registration Number
BR-1479
Brand Name
Bevalast
Generic Name
Bevacizumab
Dosage Form
Concentrate for Solution for Infusion (IV)
Dosage Strength
25 mg/mL
Manufacturer
Joint Stock Company Biocad
Importer
Qualimed Pharma Inc.
Issuance Date
28 February 2024
Expiry Date
28 February 2029
Pharmacologic Category
Monoclonal Antibodies
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
538a7e82c761f90a
Type
Standard
Back to Philippines FDA Approvals